INTERNATIONAL PATENT: PLIANT THERAPEUTICS, INC. FILES APPLICATION FOR "INTEGRIN INHIBITORS FOR REVERSAL OF FIBROSIS AND COLLAGEN DEPOSITION"

GENEVA, Nov. 25 -- PLIANT THERAPEUTICS, INC. (331 Oyster Point BoulevardSouth San Francisco, California 94080) filed a patent application (PCT/US2025/028697) for "INTEGRIN INHIBITORS FOR REVERSAL OF FIBROSIS AND COLLAGEN DEPOSITION" on May 09, 2025. With publication no. WO/2025/240262, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COSGROVE, Gregory P. (c/o Pliant Therapeutics, Inc.331 Oyster Point BoulevardSouth San Francisco, California 94080), TURNER, Scott (c/o Pliant Therapeutics, Inc.331 Oyster Point BoulevardSouth...